1. Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit
   Hans Herbert Steiner et al, 2004, Journal of Clinical Oncology CrossRef
2. Newcastle disease virus suppresses angiogenesis in mammary adenocarcinoma models
   A. M. Al-Shammari et al, 2022, BULGARIAN JOURNAL OF VETERINARY MEDICINE CrossRef
3. Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
   Bharat Burman et al, 2020, Cancers CrossRef
4. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
   Zong Sheng Guo et al, 2014, Frontiers in Oncology CrossRef
5. Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity
   Fiona Errington et al, 2008, The Journal of Immunology CrossRef
6. Newcastle disease virus - effective alliance in the fight against cancer
   A. O. Sitkovskaya et al, 2019, Siberian journal of oncology CrossRef
7. Comparative Efficacy of Preoperative, Postoperative, and Perioperative Treatments for Resectable Colorectal Liver Metastases: A Network Meta-Analysis
   Chao Huang et al, 2019, Frontiers in Pharmacology CrossRef
8. Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
   Volker Schirrmacher, 2022, Biomedicines CrossRef
9. Antitumor Vaccination in Patients with Head and Neck Squamous Cell Carcinomas with Autologous Virus-Modified Tumor Cells
   Jochen Karcher et al, 2004, Cancer Research CrossRef
10. Recent advances of oncolytic virus in cancer therapy
    Moumita Mondal et al, 2020, Human Vaccines & Immunotherapeutics CrossRef
11. Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
    Chigozirim N. Ekeke et al, 2021, Annals of Surgical Oncology CrossRef
12. Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
    Qayssar A. Obaid et al, 2022, Frontiers in Molecular Biosciences CrossRef